Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

disease progression

- PMLiVE

NHS taps technology firms for ‘connected’ patient projects

One of the pilots will see Google's Verily unit work with MSD on a telehealth initiative

- PMLiVE

UCB wins European approval for epilepsy drug Briviact

Plans first launches within weeks

- PMLiVE

Merck KGaA adds two to its executive board

Appoints Udit Batra and Walter Galinat, while Bernd Reckmann will retire

- PMLiVE

Germany’s Merck triumphs in court battle with US namesake

English court rules Merck & Co breached the firms' naming agreement

EU flag

Biogen-Samsung’s Enbrel biosimilar cleared for EU marketing

The companies plan to launch the treatment in the coming weeks

- PMLiVE

Adapting to the digital consumer

The trends affecting all segments of the wider healthcare ecosystem

- PMLiVE

Pragmatic digital health

Pharma will have to move beyond tech hype if its digital efforts are to have a genuine impact

- PMLiVE

Syndax teams with Merck/Pfizer on immuno-oncology combo

Oral cancer drug entinostat to test with avelumab

12 Connected Health

Seizing the opportunities in a new era of care

Havas Lynx

- PMLiVE

Merck abandons evofosfamide as two trials fail

Solid tumour candidate underwhelms in phase III studies

- PMLiVE

GSK earns expanded approval for Volibris in Europe

Additional indication given to pulmonary arterial hypertension drug

Roche Basel Switzerland

Roche gets EU green light for Cotellic

Approved in combination with Zelboraf for melanoma

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links